Emergent BioSolutions Inc. ( EBS) - Stock Earnings
EBS Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
EBS Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -54.6 million USD | 148.7 million USD |
| 2026Q1 | 6.8 million USD | 156.1 million USD |
| 2026Q2 | -180.2 million USD | 234.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
EBS Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -760.5 million USD | 1.0 billion USD |
| 2024 | -190.6 million USD | 1.0 billion USD |
| 2025 | 52.6 million USD | 742.9 million USD |
| 2026 Est. | — | — |
EBS
Price: $6.38
Earnings Per Share: -3.15 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 633400
Ebitda: 58.1 millionMarket Capitalization: 364.8 million